Literature DB >> 7822044

Use of heme and hemoglobin by Escherichia coli O157 and other Shiga-like-toxin-producing E. coli serogroups.

D Law1, J Kelly.   

Abstract

The virulence properties of Escherichia coli O157 isolates were compared with those of Shiga-like-toxin-producing E. coli of non-O157 serogroups. The growth of all E. coli O157 isolates was stimulated by both heme and hemoglobin, and all produced enterohemolysin. The incidence of these properties was significantly lower in the non-O157 isolates. This may contribute to the greater virulence and higher incidence of human infection caused by E. coli O157.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7822044      PMCID： PMC173054          DOI： 10.1128/iai.63.2.700-702.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  24 in total

1.  Properties of strains of Escherichia coli O26:H11 in relation to their enteropathogenic or enterohemorrhagic classification.

Authors:  S M Scotland; G A Willshaw; H R Smith; B Rowe
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

Review 2.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

Review 3.  The epidemiologic, clinical, and microbiologic features of hemorrhagic colitis.

Authors:  L W Riley
Journal:  Annu Rev Microbiol       Date:  1987       Impact factor: 15.500

4.  Virulence of iron transport mutants of Shigella flexneri and utilization of host iron compounds.

Authors:  K M Lawlor; P A Daskaleros; R E Robinson; S M Payne
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

5.  Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects.

Authors:  H Kleanthous; H R Smith; S M Scotland; R J Gross; B Rowe; C M Taylor; D V Milford
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

6.  A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells.

Authors:  A E Jerse; J Yu; B D Tall; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  A longitudinal study of Vero cytotoxin producing Escherichia coli in cattle calves in Sri Lanka.

Authors:  A M Tokhi; J S Peiris; S M Scotland; G A Willshaw; H R Smith; T Cheasty
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

8.  Occurrence and phenotypic properties of verotoxin producing Escherichia coli in sporadic cases of gastroenteritis.

Authors:  A P Burnens; P Boss; F Orskov; I Orskov; U B Schaad; F Müller; R Heinzle; J Nicolet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

9.  Genetic evidence of clonal descent of Escherichia coli O157:H7 associated with hemorrhagic colitis and hemolytic uremic syndrome.

Authors:  T S Whittam; I K Wachsmuth; R A Wilson
Journal:  J Infect Dis       Date:  1988-06       Impact factor: 5.226

10.  Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli.

Authors:  L Beutin; M A Montenegro; I Orskov; F Orskov; J Prada; S Zimmermann; R Stephan
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948
View more
  19 in total

1.  Cytotoxicity potential and genotypic characterization of Escherichia coli isolates from environmental and food sources.

Authors:  Yadilka Maldonado; Jennifer C Fiser; Cindy H Nakatsu; Arun K Bhunia
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

2.  Identification of an Escherichia coli O157:H7 heme oxygenase with tandem functional repeats.

Authors:  Michael D L Suits; Gour P Pal; Kanji Nakatsu; Allan Matte; Miroslaw Cygler; Zongchao Jia
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

3.  TonB-dependent systems of uropathogenic Escherichia coli: aerobactin and heme transport and TonB are required for virulence in the mouse.

Authors:  A G Torres; P Redford; R A Welch; S M Payne
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  Enterohemolytic phenotypes and genotypes of shiga toxin-producing Escherichia coli O111 strains from patients with diarrhea and hemolytic-uremic syndrome.

Authors:  H Schmidt; H Karch
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

Review 5.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Development of a PCR-restriction fragment length polymorphism assay for the epidemiological analysis of Shiga toxin-producing Escherichia coli.

Authors:  Kensuke Shima; Jun Terajima; Toshio Sato; Kazuhiko Nishimura; Kazumichi Tamura; Haruo Watanabe; Yoshifumi Takeda; Shinji Yamasaki
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

Review 7.  Haemolytic uraemic syndrome.

Authors:  W L Robson
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.022

8.  Crystal structure and biochemical features of EfeB/YcdB from Escherichia coli O157: ASP235 plays divergent roles in different enzyme-catalyzed processes.

Authors:  Xiuhua Liu; Qian Du; Zhi Wang; Deyu Zhu; Yan Huang; Ning Li; Tiandi Wei; Sujuan Xu; Lichuan Gu
Journal:  J Biol Chem       Date:  2011-02-15       Impact factor: 5.157

Review 9.  Insights into the biology of Escherichia coli through structural proteomics.

Authors:  Allan Matte; Zongchao Jia; S Sunita; J Sivaraman; Miroslaw Cygler
Journal:  J Struct Funct Genomics       Date:  2007-08-01

10.  Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease.

Authors:  Mohamed A Karmali; Mariola Mascarenhas; Songhai Shen; Kim Ziebell; Shelley Johnson; Richard Reid-Smith; Judith Isaac-Renton; Clifford Clark; Kris Rahn; James B Kaper
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.